Tumor-associated immune parameters for personalized patient care

Science Translational Medicine

Volumn 5, Issue 214, 2013, Pages

  Pagès, Franck ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CELL; CANCER PROGNOSIS; CELL INFILTRATION; CELL TYPE; CELLULAR DISTRIBUTION; CLONAL VARIATION; DNA DETERMINATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; INFLAMMATORY INFILTRATE; NONHUMAN; NOTE; PATIENT CARE; PERSONALIZED MEDICINE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNE INFILTRATE; TUMOR IMMUNITY;

FEMALE; GENOMICS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTES, TUMOR-INFILTRATING; OVARIAN NEOPLASMS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 84891695511     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007942     Document Type: Note

References (10)

1. H. S. Robins, N. G. Ericson, J. Guenthoer, K. C. O'Briant, M. Tewari, C. W. Drescher, J. H. Bielas, Digital Genomic Quantification of Tumor-Infiltrating Lymphocytes. Sci. Transl. Med. 5, 214ra169 (2013).
2. W. H. Fridman, F. Pagès, C. Sautès-Fridman, J. Galon, The immune contexture in human tumours: Impact on clinical outcome. Nat. Rev. Cancer 12, 298-306 (2012).
3. J. Galon, A. Costes, F. Sanchez-Cabo, A. Kirilovsky, B. Mlecnik, C. Lagorce-Pagès, M. Tosolini, M. Camus, A. Berger, P. Wind, F. Zinzindohoué, P. Bruneval, P. H. Cugnenc, Z. Trajanoski, W. H. Fridman, F. Pagès, Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960-1964 (2006).
4. D. Hanahan, R. A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
5. R. D. Schreiber, L. J. Old, M. J. Smyth, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570 (2011).
6. G. Bindea, B. Mlecnik, M. Tosolini, A. Kirilovsky, M. Waldner, A. C. Obenauf, H. Angell, T. Fredriksen, L. Lafontaine, A. Berger, P. Bruneval, W. H. Fridman, C. Becker, F. Pagès, M. R. Speicher, Z. Trajanoski, J. Galon, Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782-795 (2013).
7. T. L. Whiteside, Immune responses to cancer: Are they potential biomarkers of prognosis? Front. Oncol. 3, 107 (2013).
8. E. Zorn, T. Hercend, A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion. Eur. J. Immunol. 29, 602-607 (1999).
9. J. Galon, F. Pagès, F. M. Marincola, M. Thurin, G. Trinchieri, B. A. Fox, T. F. Gajewski, P. A. Ascierto, The immune score as a new possible approach for the classification of cancer. J. Transl. Med. 10, 1-4 (2012).
10. L. H. Butterfield, A. K. Palucka, C. M. Britten, M. V. Dhodapkar, L. Håkansson, S. Janetzki, Y. Kawakami, T. O. Kleen, P. P. Lee, C. Maccalli, H. T. Maecker, V. C. Maino, M. Maio, A. Malyguine, G. Masucci, G. Pawelec, D. M. Potter, L. Rivoltini, L. G. Salazar, D. J. Schendel, C. L. Slingluff, Jr, W. Song, D. F. Stroncek, H. Tahara, M. Thurin, G. Trinchieri, S. H. van Der Burg, T. L. Whiteside, J. M. Wigginton, F. Marincola, S. Khleif, B. A. Fox, M. L. Disis, Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin. Cancer Res. 17, 3064-3076 (2011).